TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.220
-0.010 (-0.24%)
Apr 10, 2026, 4:00 PM EDT - Market closed
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $259.17 million as of April 13, 2026. Its market cap has increased by 52.32% in one year.
Market Cap
259.17M
Enterprise Value
273.17M
1-Year Change
52.32%
Ranking
Category
Stock Price
$4.22
Market Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has decreased from $328.75M to $259.17M, a decrease of -21.17%. That is a compound annual growth rate of -4.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 259.17M | -25.69% |
| Dec 31, 2025 | 348.75M | 128.28% |
| Dec 31, 2024 | 152.77M | -31.30% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Delcath Systems | 345.92M |
| Standard BioTools | 345.33M |
| CapsoVision | 311.49M |
| RxSight | 281.85M |
| Senseonics Holdings | 279.24M |
| 908 Devices | 266.89M |
| ClearPoint Neuro | 257.48M |
| Profound Medical | 215.50M |